mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-07 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-07 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.25 |
1e-06 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-06 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |